Actively Recruiting
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
Led by Mayo Clinic · Updated on 2026-03-10
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating health-related quality of life and urinary outcomes in patients who have undergone either partial cystectomy or matched radical cystectomy for bladder carcinoma. This observational study aims to compare these outcomes through patient-filled questionnaires and to understand how patient-specific factors, such as demographics and clinicopathologic characteristics, may influence variations in these results. Participants include patients who have had partial cystectomy or radical cystectomy, with a focus on those currently living and recorded in Mayo Urology's cystectomy registry. Patients complete questionnaires about their urinary health and quality of life. The study does not involve any interventional treatments but observes and collects data from these two patient groups. During the study, patients will provide information via questionnaires and allow review of their medical records. The primary outcomes measured include health-related quality of life using the EORTC QLQ-C30 questionnaire and self-reported urinary outcomes, both tracked for up to one year. This monitoring helps researchers understand the impact of the surgical procedures on patients' well-being over time, with the study planned through early 2027.
CONDITIONS
Brief Title
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently living partial cystectomy patients in Mayo Urology's cystectomy registry and patients undergoing radical or partial cystectomy
- Matched 2:1 living radical cystectomy to partial cystectomy patients
- Either urothelial or non-urothelial histology
You will not qualify if you...
- Partial cystectomy patients that underwent subsequent radical cystectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 1 year
Participants complete questionnaires and have their medical records reviewed to explore health-related quality of life and urinary outcomes.
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here